# Preemptive Endoluminal Negative Pressure in Minimally Invasive Transthoracic Esophagectomy

> **NCT04162860** · NA · UNKNOWN · sponsor: **University of Zurich** · enrollment: 100 (estimated)

## Conditions studied

- Esophageal Cancer
- Surgery--Complications
- Leak, Anastomotic

## Interventions

- **DEVICE:** Eso-SPONGE® device

## Key facts

- **NCT ID:** NCT04162860
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-04
- **Primary completion:** 2020-12
- **Final completion:** 2021-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04162860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04162860, "Preemptive Endoluminal Negative Pressure in Minimally Invasive Transthoracic Esophagectomy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04162860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*